Updated:
Morningside Venture Partners
Gerald Chan's Morningside Venture Partners has backed DJI and Wuxi Biologics using capital from the Hang Lung real estate fortune since 1986.
Morningside Venture Partners
Gerald Chan and his brother Ronnie co-steward the wealth generated by Hang Lung Group, the Hong Kong property developer their father founded. While Ronnie oversees the listed real estate business, Gerald directs the family's technology and healthcare investments through Morningside. The firm established an early and enduring presence in mainland China's venture ecosystem, setting up offices in Shanghai and Beijing before the country's tech boom accelerated. Morningside operates across the capital structure with a concentration on early-stage and growth equity, though the family's perpetual time horizon allows it to hold positions across full company lifecycles. Asset-class exposure spans direct venture investments, private equity, and public equities, with a geographic footprint covering Greater China, North America, and Europe. The portfolio's historical density in biotechnology and life sciences is exemplified by long-held positions in Wuxi AppTec, the contract research giant, and Wuxi Biologics. The firm is also active in robotics and industrial technology, backing companies like DJI, the civilian drone manufacturer in which it was an early institutional investor. Morningside operates through a network of affiliated entities under the Morningside Group umbrella rather than a single consolidated balance sheet, a structure that gives individual investment teams regional and sector-specific mandates. The firm has backed over 100 companies and maintains offices in Shanghai, Hong Kong, Boston, and London. Gerald Chan also directs the Morningside Foundation, which has made substantial gifts to Harvard University's School of Public Health and MIT. The family's posture combines a global sourcing model — the Boston office meaningfully scouts for therapeutics and medtech — with a willingness to anchor US dollar and RMB-denominated funds. Morningside's structural differentiator is its dual identity: it is legally a single-family office but culturally and operationally indistinguishable from a multi-strategy venture capital firm, with dedicated partners, sector specialists, and multi-office sourcing that predates the professionalization trend among family offices by decades.
General information
Firm type
Venture Capital
Year founded
1986
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Additional offices
Hong Kong · Boston, MA · London, UK
Principals
Gerald Chan
Founder
Ronnie Chan
Chairman, Hang Lung Group
Frances Kang
Managing Director
Sector focus
Frequently asked questions
Who runs investment decisions at Morningside Venture Partners?
Gerald Chan directs the overall investment strategy for the Morningside Group. Day-to-day investment decisions are made by a team of managing directors and partners operating from Shanghai, Hong Kong, Boston, and London. The firm operates with a decentralized sector-specialist model, where senior investment professionals have authority over deals within their mandates.
Is Morningside structured as a single family office or does it operate more like a venture firm?
Morningside is legally a single-family office managing the Chan family's capital, but it functions like an institutional venture capital firm. It employs dedicated investment partners, maintains multiple international offices, and competes directly with top-tier venture funds for deal allocation. The firm does not raise external capital, which gives it a permanent capital base unusual among venture investors.
How does Morningside source proprietary deal flow?
Morningside sources through a network built since 1986 across Greater China and Boston's life-science corridor. The firm leverages Gerald Chan's academic connections — he holds a Ph.D. from Harvard and has deep ties to MIT and Harvard Medical School — to access pre-institutional therapeutics and medtech companies. In China, decades of early backing for founders in biotechnology and deep tech have created a proprietary referral network.
What are Morningside's most notable historical investments?
Two of Morningside's most significant investments are Wuxi AppTec and DJI. The firm was an early backer of Wuxi AppTec, the Shanghai and Hong Kong-listed pharmaceutical R&D services platform, and its biologics spin-out Wuxi Biologics. Morningside also invested early in DJI before the Shenzhen company became the global leader in civilian drones.
Where does the underlying wealth come from?
The wealth originates from Hang Lung Group, the Hong Kong-based real estate developer founded by Chan Tseng-hsi. His sons Gerald and Ronnie inherited and expanded the business; Ronnie chairs the publicly listed Hang Lung Properties, which develops and operates high-end commercial and retail properties across Hong Kong and mainland China. Gerald directs the portion of family capital allocated to technology and life-science investments through Morningside.
Does Morningside maintain philanthropic structures?
Yes, the Morningside Foundation, directed by Gerald Chan, is a significant philanthropic vehicle separate from the investment operations. The foundation has made notable grants including a $350 million gift to the Harvard T.H. Chan School of Public Health, named for the family patriarch, and a $100 million gift to MIT for a neuroscience research center (per Boston Globe, 2014). Philanthropic activities and investment decisions operate under separate governance.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: